Effect of Etelcalcetide vs Cinacalcet on Serum Parathyroid Hormone in Patients Receiving Hemodialysis With Secondary Hyperparathyroidism: A Randomized Clinical Trial. [electronic resource]
Producer: 20170209Description: 156-164 p. digitalISSN:- 1538-3598
- Administration, Oral
- Biomarkers -- blood
- Calcimimetic Agents -- administration & dosage
- Calcium -- administration & dosage
- Cinacalcet -- administration & dosage
- Double-Blind Method
- Female
- Fibroblast Growth Factor-23
- Fibroblast Growth Factors -- blood
- Humans
- Hyperparathyroidism, Secondary -- blood
- Infusions, Intravenous
- Kidney Failure, Chronic -- complications
- Male
- Middle Aged
- Nausea -- chemically induced
- Parathyroid Hormone -- blood
- Peptides -- administration & dosage
- Renal Dialysis
- Time Factors
- Vomiting -- chemically induced
No physical items for this record
Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, U.S. Gov't, Non-P.H.S.
There are no comments on this title.
Log in to your account to post a comment.